- Researchers from Fox Chase Cancer Center in Philadelphia published a new research perspective on targeting inflammatory factors for chemoprevention and cancer interception in mesothelioma.
- Mesothelioma is an incurable cancer caused by exposure to asbestos, with inflammation and genetic factors contributing to its development and treatment resistance.
- The perspective discusses preclinical mouse models, potential targets for prevention, and the use of natural and synthetic agents in studies.
- Previous clinical trials on chemoprevention in asbestos-exposed populations are reviewed, along with considerations for future research.
- The research aims to develop novel approaches to treat mesothelioma and reduce the overall incidence of this fatal disease.
Source link
Oncology